AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $203.30 million. The enterprise value is $187.07 million.
| Market Cap | 203.30M |
| Enterprise Value | 187.07M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 25.80 million shares outstanding.
| Shares Outstanding | 25.80M |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 28.63% |
| Float | 24.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.95 |
| Forward PS | 2.38 |
| PB Ratio | 9.36 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.25, with a Debt / Equity ratio of 1.35.
| Current Ratio | 7.25 |
| Quick Ratio | 6.35 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.94 |
Financial Efficiency
Return on equity (ROE) is -84.10% and return on invested capital (ROIC) is -65.38%.
| Return on Equity (ROE) | -84.10% |
| Return on Assets (ROA) | -47.60% |
| Return on Capital (ROIC) | -65.38% |
| Revenue Per Employee | $248,783 |
| Profits Per Employee | -$216,517 |
| Employee Count | 207 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.53 |
Taxes
In the past 12 months, AVITA Medical has paid $43,998 in taxes.
| Income Tax | 43,998 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.39% in the last 52 weeks. The beta is 1.55, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | -52.39% |
| 50-Day Moving Average | 8.55 |
| 200-Day Moving Average | 12.42 |
| Relative Strength Index (RSI) | 38.48 |
| Average Volume (20 Days) | 252,695 |
Short Selling Information
| Short Interest | 2.03M |
| Short Previous Month | 1.88M |
| Short % of Shares Out | 7.91% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.61 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $51.50 million and -$44.82 million in losses. Loss per share was -$1.17.
| Revenue | 51.50M |
| Gross Profit | 29.25M |
| Operating Income | -33.30M |
| Pretax Income | -29.83M |
| Net Income | -44.82M |
| EBITDA | -27.17M |
| EBIT | -28.17M |
| Loss Per Share | -$1.17 |
Balance Sheet
The company has $45.45 million in cash and $29.22 million in debt, giving a net cash position of $16.23 million or $0.63 per share.
| Cash & Cash Equivalents | 45.45M |
| Total Debt | 29.22M |
| Net Cash | 16.23M |
| Net Cash Per Share | $0.63 |
| Equity (Book Value) | 21.71M |
| Book Value Per Share | 0.84 |
| Working Capital | 49.41M |
Cash Flow
In the last 12 months, operating cash flow was -$33.20 million and capital expenditures -$1.50 million, giving a free cash flow of -$34.70 million.
| Operating Cash Flow | -33.20M |
| Capital Expenditures | -1.50M |
| Free Cash Flow | -34.70M |
| FCF Per Share | -$1.35 |
Margins
Gross margin is 56.79%, with operating and profit margins of -64.66% and -87.03%.
| Gross Margin | 56.79% |
| Operating Margin | -64.66% |
| Pretax Margin | -57.93% |
| Profit Margin | -87.03% |
| EBITDA Margin | -52.77% |
| EBIT Margin | -54.70% |
| FCF Margin | -67.37% |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.73% |
| Shareholder Yield | -1.73% |
| Earnings Yield | -22.05% |
| FCF Yield | -17.07% |
Analyst Forecast
The average price target for AVITA Medical is $24.25, which is 207.74% higher than the current price. The consensus rating is "Buy".
| Price Target | $24.25 |
| Price Target Difference | 207.74% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 27.95% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
AVITA Medical has an Altman Z-Score of -1.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.42 |
| Piotroski F-Score | 3 |